|
|
Post by mnkdfann on Nov 2, 2017 11:07:34 GMT -5
Because they don't have enough to sustain operations . . . which means there is another raise coming in the future and if he continues to play nice they may get a piece of the next round. Analysts show their teeth once in a while to remind the company who writes the research, that the research isn't really free, and that the teeth can either smile at you or bite back. Message delivered. no guarantees of such, that is an assumption, it doesn't mean squadoosh or it could mean that Mike either sees funds coming from something or someone else....how does the analyst know for sure? Are you insinuating that he has some type of inside information of an additional capital raise/direct offering/ and not Mike waiting to use the ATM or some other vehicle? He looks like an idiot and sour grapes and his third tier firm would have been better served playing with sugar to get honey rather than throw a tantrum at missing out on the last one. How's his track record post his recommendations?Jason Kolbert's track record is horrible, which is why his earlier upgrade of MNKD was really meaningless (as a positive indicator, that is) at the time. It was (IMO) always abundantly clear that he was pimping himself out, hoping for business. www.tipranks.com/analysts/jason-kolbert |
|
|
|
Post by Omega on Nov 2, 2017 11:14:50 GMT -5
Jason Kolbert
-Maxim Group
Ranked #4,638 out of 4,702 Analysts on TipRanks
(#10,838 out of 10,917 overall experts)
Success Rate
33%
122 out of 371 ratings were successful
Average Return
-9.0%
Average return per rating
|
|
|
|
Post by radgray68 on Nov 2, 2017 11:15:39 GMT -5
Green hill got us $150 million up front with the old, crappy label. Green hill is still negotiating, but no mention by any analyst of the possible up front for other markets. " Nobody here at Mannkind is worried" - MC
Just loaded up at $3 - so psyched
|
|
|
|
Post by olderteampt on Nov 2, 2017 13:25:07 GMT -5
As soon as I find an analyst smarter then Al Mann I will follow their lead.
|
|
|
|
Post by radgray68 on Nov 2, 2017 13:38:43 GMT -5
Is it my imagination? Or, is it not customary for so-called analysts to wait until the quarterly numbers are ACTUALLY published before issuing downgrades, negative spins, fear, uncertainty and doubt? Usually, Mannkind does the conference call, gives some positive news, THEN they get hammered from all sides. It's almost like they're trying to get out in front of something this time. Just seems kinda hinky.
|
|
|
|
Post by peppy on Nov 2, 2017 13:41:18 GMT -5
this is what MXIM said four weeks ago. 
|
|
|
|
Post by mnkdfann on Nov 2, 2017 13:44:01 GMT -5
Is it my imagination? Or, is it not customary for so-called analysts to wait until the quarterly numbers are ACTUALLY published before issuing downgrades, negative spins, fear, uncertainty and doubt ... That's your imagination. Analysts change ratings all the time, whenever anything they think meaningful occurs, not only when quarterly numbers are reported. |
|
|
|
Post by bioexec25 on Nov 2, 2017 13:47:23 GMT -5
Is it my imagination? Or, is it not customary for so-called analysts to wait until the quarterly numbers are ACTUALLY published before issuing downgrades, negative spins, fear, uncertainty and doubt? Usually, Mannkind does the conference call, gives some positive news, THEN they get hammered from all sides. It's almost like they're trying to get out in front of something this time. Just seems kinda hinky. Maybe this is how they achieve such a less than stellar success rate. Of course perhaps they are scaring retails for one of their big brothers so they can hoard the shares. I don't pay much attention to analysts, they're on par with media talking heads in my book. |
|
|
|
Post by awesomo on Nov 2, 2017 13:53:23 GMT -5
Is it my imagination? Or, is it not customary for so-called analysts to wait until the quarterly numbers are ACTUALLY published before issuing downgrades, negative spins, fear, uncertainty and doubt? Usually, Mannkind does the conference call, gives some positive news, THEN they get hammered from all sides. It's almost like they're trying to get out in front of something this time. Just seems kinda hinky. Welcome to Wall Street, where every firm/analyst has their own agenda. Often times, they might as well be throwing darts. |
|
|
|
Post by matt on Nov 3, 2017 7:11:02 GMT -5
Because they don't have enough to sustain operations . . . which means there is another raise coming in the future and if he continues to play nice they may get a piece of the next round. Analysts show their teeth once in a while to remind the company who writes the research, that the research isn't really free, and that the teeth can either smile at you or bite back. Message delivered. no guarantees of such, that is an assumption, it doesn't mean squadoosh or it could mean that Mike either sees funds coming from something or someone else....how does the analyst know for sure? Are you insinuating that he has some type of inside information of an additional capital raise/direct offering/ and not Mike waiting to use the ATM or some other vehicle? He looks like an idiot and sour grapes and his third tier firm would have been better served playing with sugar to get honey rather than throw a tantrum at missing out on the last one. How's his track record post his recommendations? The company is not generating positive cash flow, and anybody who knows how to read a financial statement knows that, so another raise is coming if MNKD is to remain in business. You are correct that those funds could come from any source, not necessarily secondary offerings, but "something or someone else" is a lot less likely method for a public company to get funding than the secondary market. The issue here is that MNKD made a strategic blunder by not directing part of the deal to Maxim. When a company writes research on your firm, the quid pro quo is that the banker gets a taste of the next financing. It is not necessarily a guarantee of 100% of the deal, but the company can direct the lead bank to share the offering with other firms in particular percentages, just as they can direct a portion of an IPO to particular investors. The rules of the game are largely unwritten, but widely understood. When you are a multi-billion dollar giant with investment grade securities you can shop for the investment bank that suits your taste, but a company like MNKD cannot access most of the large investment banks. For a smaller firm like MNKD it makes sense to have lots of friends, and very few enemies, on Wall Street. |
|
|
|
Post by lb on Nov 3, 2017 7:58:05 GMT -5
Maybe they got spooked by a recent lawsuit and decided to play it safe with no price target?
|
|
|
|
Post by peppy on Nov 3, 2017 8:13:46 GMT -5
no guarantees of such, that is an assumption, it doesn't mean squadoosh or it could mean that Mike either sees funds coming from something or someone else....how does the analyst know for sure? Are you insinuating that he has some type of inside information of an additional capital raise/direct offering/ and not Mike waiting to use the ATM or some other vehicle? He looks like an idiot and sour grapes and his third tier firm would have been better served playing with sugar to get honey rather than throw a tantrum at missing out on the last one. How's his track record post his recommendations? You are correct that those funds could come from any source, not necessarily secondary offerings, but "something or someone else" is a lot less likely method for a public company to get funding than the secondary market. The issue here is that MNKD made a strategic blunder by not directing part of the deal to Maxim. When a company writes research on your firm, the quid pro quo is that the banker gets a taste of the next financing. It is not necessarily a guarantee of 100% of the deal, but the company can direct the lead bank to share the offering with other firms in particular percentages, just as they can direct a portion of an IPO to particular investors. The rules of the game are largely unwritten, but widely understood. When you are a multi-billion dollar giant with investment grade securities you can shop for the investment bank that suits your taste, but a company like MNKD cannot access most of the large investment banks. For a smaller firm like MNKD it makes sense to have lots of friends, and very few enemies, on Wall Street. The earnings conference call Tuesday morning. I am interested to see if Mike has something concrete he can tell us about insurance coverage with the new label. I am also interested to see if something UAE turns up for the occasion. www.screencast.com/t/AmU1k7Npemjc www.screencast.com/t/gAij0ZukP
With insurance coverage, and a few prescribing physicians, exponential growth should not be ruled out. Especially now with the continuous glucose monitors being rolled out... of sorts. Mike seems to be doing a good job rolling out low cost fast clinical trial data. Do not rule out, diabetics going toe to toe with physicians. we only need 10,000 type one diabetics to have afrezza covered by insurance and to go toe to toe with their physicians. We have all witnessed aged, he will go toe to toe. He is not that interested. Some people are soooooooo interested. www.screencast.com/t/WQzl6sftvr
So as pessimistic as I am about what is going on, on the planet; There is a system, that is these moments MNKD is playing toe to toe in. That thing that MNKD has going for it is AFREZZA really is this good. waaa waaa poor MAXIM and their chit.
A new pencil can be taken to the paper Tuesday.
|
|
|
|
Post by akemp3000 on Nov 3, 2017 10:10:15 GMT -5
It's highly doubtful another raise will be required. Mike's new strategy has created the start of Afrezza growth which will continue to lower the burn rate moving forward. He has also created a pipeline of many other positive developments germinating in many directions. We simply don't know what's going on behind the scenes to even guess which ones will bear fruit first. A balance sheet records the past but doesn't recognize ongoing and upcoming events happening behind the scenes. If there were truly nothing much going on, then there would especially be no need for another raise...just saying.
|
|
|
|
Post by jred on Nov 3, 2017 11:13:28 GMT -5
no guarantees of such, that is an assumption, it doesn't mean squadoosh or it could mean that Mike either sees funds coming from something or someone else....how does the analyst know for sure? Are you insinuating that he has some type of inside information of an additional capital raise/direct offering/ and not Mike waiting to use the ATM or some other vehicle? He looks like an idiot and sour grapes and his third tier firm would have been better served playing with sugar to get honey rather than throw a tantrum at missing out on the last one. How's his track record post his recommendations? The company is not generating positive cash flow, and anybody who knows how to read a financial statement knows that, so another raise is coming if MNKD is to remain in business. You are correct that those funds could come from any source, not necessarily secondary offerings, but "something or someone else" is a lot less likely method for a public company to get funding than the secondary market. The issue here is that MNKD made a strategic blunder by not directing part of the deal to Maxim. When a company writes research on your firm, the quid pro quo is that the banker gets a taste of the next financing. It is not necessarily a guarantee of 100% of the deal, but the company can direct the lead bank to share the offering with other firms in particular percentages, just as they can direct a portion of an IPO to particular investors. The rules of the game are largely unwritten, but widely understood. When you are a multi-billion dollar giant with investment grade securities you can shop for the investment bank that suits your taste, but a company like MNKD cannot access most of the large investment banks. For a smaller firm like MNKD it makes sense to have lots of friends, and very few enemies, on Wall Street. Strategic blunder? imo that is a significant overstatement. So according to your theory, all Maxim has to do is issue positive research reports for any non "multi-billion dollar giant" who might need future capital raising to guarantee business for themselves? If that is how it actually worked Maxim would have one heck of business. I know it's not guaranteed, but then the company will feel the "bite" right? As I am writing this MNKD is up .20 since his "bite back" note came out - with reactions like that have at it Jason. Do you think any serious investor is looking to Maxim and Jason Kolbert to make significant investment decisions? Would you? And his reason for the downgrade - future capital raise is a joke. Even though this was known by even the casual follower of the MNKD story, it's starting to bother Jason now? - child please! And if Jason knows how to read financial statements he would have realized the limited available unissued shares would have prevented the capital raise that he is suddenly disappointed has happened yet. Not denying the web of influence that research reports have on the investment management business, but without knowing the what's going on behind the scenes declaring it a blunder seems unfair to MNKD management. And agreed imo, MNKD will need future capital raises and most likely the secondary market and the placement of those preferred shares will be involved. The size necessary will be a function of the deals management is able to strike and the revenue from scripts - the better they are the less the capital raise will need to be. Adding my own unsubstantiated speculation - Jason's report has more to do with Maxim trying to get on Deerfield's good side - by effecting the near term vwap - than it does with MNKD. If you are an unethical research/investment management group that isn't much concerned with your reputation on the street, you are looking to suck up to Deerfield, who can provide much more business down the line. |
|
|
|
Post by agedhippie on Nov 3, 2017 13:41:17 GMT -5
... The issue here is that MNKD made a strategic blunder by not directing part of the deal to Maxim. When a company writes research on your firm, the quid pro quo is that the banker gets a taste of the next financing. It is not necessarily a guarantee of 100% of the deal, but the company can direct the lead bank to share the offering with other firms in particular percentages, just as they can direct a portion of an IPO to particular investors. The rules of the game are largely unwritten, but widely understood. When you are a multi-billion dollar giant with investment grade securities you can shop for the investment bank that suits your taste, but a company like MNKD cannot access most of the large investment banks. For a smaller firm like MNKD it makes sense to have lots of friends, and very few enemies, on Wall Street. ... Adding my own unsubstantiated speculation - Jason's report has more to do with Maxim trying to get on Deerfield's good side - by effecting the near term vwap - than it does with MNKD. If you are an unethical research/investment management group that isn't much concerned with your reputation on the street, you are looking to suck up to Deerfield, who can provide much more business down the line. So the executive summary is that we have no way to decide why Maxim (or any other analyst) does what they do other than that somehow it's in their best interests! |
|
